Carboxyfullerene prevents iron-induced oxidative stress in rat brain

Journal of Neurochemistry

Volumn 72, Issue 4, 1999, Pages 1634-1640

  Lin, Anya M Y ^a   Chyi, B Y ^a   Wang, S D ^b   Yu, H H ^b   Kanakamma, P P ^b   Luh, T Y ^b   Chou, C K ^a   Ho, L T ^a,c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Carboxyfullerene; Iron; K+ evoked dopamine overflow; Lipid peroxidation; Oxidative injury

Indexed keywords

CARBOXYFULLERENE; DOPAMINE; FULLERENE DERIVATIVE; IRON; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; DEGENERATIVE DISEASE; DOPAMINE BRAIN LEVEL; DOPAMINERGIC SYSTEM; DRUG MECHANISM; IMMUNOREACTIVITY; LIPID PEROXIDATION; MALE; NERVE ENDING; NEUROPROTECTION; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA;

ANIMALS; ANTIOXIDANTS; BRAIN CHEMISTRY; CARBON; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FULLERENES; IRON; LIPID PEROXIDATION; MALE; MELATONIN; NERVE DEGENERATION; OXIDATIVE STRESS; PHOTOSENSITIZING AGENTS; POTASSIUM; RATS; RATS, SPRAGUE-DAWLEY; VITAMIN E;

ANIMALIA;

EID: 0033062653     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1999.721634.x     Document Type: Article

References (44)

1. Ames B. N., Shigenaga M. K., and Hagen T. M. (1993) Oxidants, antioxidants and the degenerative disease of aging. Proc. Natl. Acad. Sci. USA 90, 7915-7922.
2. Ben-Shachar D. and Youdim M. B. H. (1991) Intranigral iron injection induces behavioral and biochemical "parkinsonism" in rats. J. Neurochem. 57, 2133-2135.
3. Chen H. H., Yu C., Ueng T. H., Cher, S., Chen B. J., Huang K. J., and Chiang L. Y. (1998) Acute and subacute toxicity study of water-soluble polyalkylsulfonated C60 in rats. Toxicol. Pathol. 26, 143-151.
4. Chiueh C. C., Zukowaka-Grojec Z., Kirk K. L., and Kopin I. J. (1983) 6-Fluorocatecholamines as false adrenergic neurotransmitters. J. Pharmacol. Exp. Ther. 225, 529-533.
5. Cohen G. and Werner P. (1994) Free radicals, oxidative stress and neurodegeneration, in Neurodegenerative Diseases (Calne D. B., ed.), pp. 139-162. Saunders, Philadelphia.
6. de la Torre M. R., Casado A., Lopez-Fernandez M. E., Carrascosa D., Casado M. C., Venarucci D., and Venarucci V. (1996) Human aging brain disorders: role of antioxidant enzymes. Neurochem Res. 21, 885-888.
7. Dexter D. T., Wells F. R., Lees A. J., Agid F., Agid Y., Jenner P., and Marsden C. D. (1989) Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52, 1830-1836.
8. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden D. C. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92-97.
9. Dugan L. L., Gabrielesen J. K., Yu S. P., Lin T. S., and Choi D. W. (1996) Buckminsterfullerenol free radical scavengers reduce excitotoxic and apoptotic death of cultured cortical neurons. Neurobiol. Dis. 3, 129-135.
10. Dugan L. L., Turetsky D. M., Du C., Lobner D., Wheeler M., Almli C. R., Shen C. K., Luh T. Y., Choi D. W., and Lin T. S. (1997) Carboxyfullerenes as neuroprotective agents. Proc. Natl. Acad. Sci. USA 94, 9434-9439.
11. Ebadi M., Srinivasan S. K., and Baxi M. D. (1996) Oxidative stress and antioxidant therapy in Parkinson's disease. Prog. Neurobiol. 48, 1-19.
12. Friedemann M. N. (1992) In vivo electrochemical studies of dopamine diffusion and clearance in the striatum of young and aged F344 rats. Age 15, 23-28.
13. Furukawa K., Estus S., Fu W., Mark R. J., and Mattson M. P. (1997) Neuroprotective action of cycloheximide involves induction of bcl-2 and antioxidant pathways. J. Cell Biol. 136, 1137-1149.
14. Gerhardt G. A. and Palmer M. (1987) Characterization of the techniques of pressure ejection and microiontophoresis using in vivo electrochemistry. J. Neurosci. Methods 22, 147-159.
15. Gerhardt G. A., Oke A. F., Nagy G., Moghaddam B., and Adams R. N. (1984) Nafion-coated electrodes with high selectivity for CNS electrochemistry. Brain Res. 290, 390-395.
16. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
17. Halliwell B. and Gutteridge J. M. (1984) Oxygen toxicity, oxygen radicals, transition metals and diseases. Biochem. J. 219, 1-14.
18. Hirsch E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33 (Suppl. 1), 52-59.
19. Hou J.-G. G., Cohen G., and Mytilineou C. (1997) Basic fibroblast growth factor stimulation of glial cells protects dopamine neurons from 6-hydroxydopamine toxicity: involvement of the glutathione system. J. Neurochem. 69, 76-83.
20. 60 by photoacoustic calorimetry. J. Phys. Chem. 95, 6073-6075.
21. Jenner P. and Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47, S161-S170.
22. Kikugawa K., Kato T., Beppu M., and Haysaaka A. (1989) Fluorescent and crosslinked protein formed by free radical and aldehyde species generated during lipid peroxidation. Adv. Exp. Med. Biol. 266, 345-356.
23. Krasnovsky A. A. Jr. and Foote C. S. (1993) Time-resolved measurements of singlet oxygen dimol-sensitized luminescence. J. Am. Chem. Soc. 115, 6013-6016.
24. 60: a new form of carbon. Nature 347, 354-358.
25. 60: Buckminsterfullerene. Nature 318, 162-163.
26. 60. Science 254, 1183-1185.
27. Lai Y. L. and Chiang L. Y. (1997) Water-soluble fullerene derivatives attenuate exsanguination-induced bronchoconstriction of guinea-pigs. J. Auton. Pharmacol. 17, 229-235.
28. Lin A. M. Y., Yang C. H., and Chui C. Y. (1998) Striatal dopamine dynamics are altered following an intranigral infusion of iron in SD rat. Free Radic. Biol. Med. 24, 988-993.
29. Mokanakumar K. P., DeBartolomeis A., Wu R. M., Yeh K. J., Sternberger L. M., Peng S., Murphy D. L., and Chiueh C. C. (1994) Ferrous citrate complex and nigral degeneration: evidence for free radical formation and lipid peroxidation. Ann. NY Acad. Sci. 738, 392-399.
30. 60 with other photosensitizer, based on 1268 nm emission. Chem. Pharm. Bull. 42, 2291-2294.
31. Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates, Academic Press, Orlando.
32. Perry T. L., Godin D. V., and Hansen A. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency. Neurosci. Lett 33, 305-310.
33. Rauhalu P., Mohanakumar K. P., Sziraki I., Lin A. M. Y., and Chiueh C. C. (1996) S-Nitrosothiols and nitric oxide but not sodium nitroprusside protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23, 58-60.
34. Rauhala P., Lin A. M. Y., and Chiueh C. C. (1998) Neuroprotection by 5-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB. J. 12, 165-173.
35. Reiter R., Tang L., Garcia J. J., and Munoz-Hoyos A. (1997) Pharmacological actions of melatonin in oxygen radical pathophysiology. Life Sci. 60, 2255-2271.
36. Satoh M., Matsuo K., Kiriya H., Mashino T., Nagano T., Hirobe M., and Takayanagi I. (1997) Inhibitory effects of fullerene derivative, dimalonic acid C60, on nitric-oxide-induced relaxation of rabbit aorta. Eur. J. Pharmacol. 327, 175-181.
37. Sengstock G. J., Olanow C. W., Dunn A. J., Barone S. Jr., and Arendash G. W. (1994) Progressive changes in striatal dopaminergic markers, nigral volume, and rotational behavior following iron infusion into the rat substantia nigra. J. Exp. Neurol. 130, 82-94.
38. Sera N., Tokiwa H., and Miyata N. (1996) Mutagenicity of the fullerene C60-generated singlet oxygen dependent formation of lipid peroxides. Carcinogenesis 17, 2163-2169.
39. Sofic E., Paulus W., Jellinger K., Riederer P., and Youdim M. B. H. (1991) Selective increase of iron in substantia nigra zona compacta of parkinsonian brains. J. Neurochem. 56, 978-982.
40. Sofic E., Lange K. W., Jellinger K., and Riederer P. (1992) Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci. Lett. 142, 128-130.
41. Su M. T., Dunwiddie T. V., Mynlieff M., and Gerhardt G. A. (1990) Electrochemical characterization of stimulated norepinephrine overflow in locus coeruleus-hippocampus double brain grafts grown in oculo. Neurosci. Lett. 110, 186-192.
42. 60, fullerenol, a novel free radical trapper, prevented hydrogen peroxide- and cumene hydroperoxide-elicited changes in rat hippocampus in vitro. J. Pharm. Pharmacol. 49, 438-445.
43. Tsuchiya T., Oguri I., Yamakoshi Y. N., and Miyata N. (1996) Novel harmful effects of [60] fullerene on mouse embryos in vitro and in vivo. FEBS Lett. 393, 139-145.
44. Youdim M. B., Ben-Shachar D., Eshel G., Finberg J. P. M., and Riederer P. (1993) The neurotoxicity of iron and nitric oxide: relevance to the etiology of Parkinson's disease, in Advances in Neurology (Narabyashi H., Nagatsu T., Yanagisawa N., and Mizuno Y., eds), pp. 259-266. Raven Press, New York.